eGlint Wins $250,000 BioTools Innovator Grand Prize
Image
San Diego – October 19, 2026 -- eGlint, Inc. won the $250,000 Grand Prize at the 2026 BioTools Innovator Capstone Competition on October 14, giving the rapid-proteomics developer fresh capital as it moves its first product, ProteoMix, toward commercialization.
eGlint beat three other finalists, Caravel, Pando Bioscience and QuantumCyte, in a live competition. The four were drawn from the 30-company 2026 accelerator cohort, which was selected from more than 550 applicants worldwide. Attendees, including life science executives, investors and strategic partners, decided the winner by live audience vote.